Qilian International - Bathi sing dikarepake QLI

Logo perusahaan publik Qilian International (QLI)

Qilian International (QLI) serves as a leading developer in the field of raw material purification and bioactive extraction. This chart of expected financial results confirms this status, where the value of captures current market expectations. The business relies on domestic consumption cycles, which establishes it as a defensive asset. However, geopolitical tensions and sanctions could complicate component logistics and international certification.

QLI - Bathi resik mangsa ngarep Qilian International Corp ing rentang 04.07.2022 - 18.11.2026

Rincian metrik lan analitis perusahaan Qilian International Corp (QLI)

Pambiji fundamental perusahaan:QLI, qlsyy.net
Produk dadi Qilian International Holding Group Limited

The implementation of ESG standards and purification systems in Qilian International (QLI) pharmaceutical production directly impacts the expected profit growth. This indicator determines the future net income of the business after deducting all operating expenses and taxes. The metric is calculated as a projected profit sum, reflecting the capital density of the asset. Positive dynamics confirm the issuer's financial stability, characterizing the securities as a moderate-risk instrument.

Pesaing Qilian International (QLI)

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|Galapagos Genomics - Penghasilan resik sing dikarepake|ANIP (ANI Pharmaceuticals Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake mannkindcorp.com MNKD|Bathi sing dikarepake Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SPRY (ARS Pharmaceuticals Inc)|Bathi resik mangsa ngarep TBPH (Theravance)|AQST - Bathi sing dikarepake|scPharmaceuticals (SCPH) - Bathi mangsa ngarep|TECX: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik TNXP|Bathi sing dikarepake China SXT Pharmaceuticals, Inc.|EPRX: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep BHST|EXOZ - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ORMP (oramed.com)|Proyeksi bathi mangsa ngarep enterabio.com ENTX|HYFT - Bathi sing dikarepake|Prakiraan bathi perusahaan ABVC BioPharma, Inc ABVC|CPIX: Proyeksi bathi mangsa ngarep|Quantum BioPharma Ltd - Penghasilan resik sing dikarepake|Bathi mangsa ngarep FGEN|Telomir Pharmaceuticals, Inc. - Bathi forward|Proyeksi bathi mangsa ngarep RANI|SNYR (Synergy CHC) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Rallybio RLYB|Lexaria Bioscience (LEXX) - Bathi resik sing dikarepake|PULM - Bathi sing dikarepake|Prakiraan bathi perusahaan Pheton Holdings PTHL|APM (Aptorum) - Bathi mangsa ngarep|Lyra Therapeutics, Inc. (LYRA) - Proyeksi bathi mangsa ngarep|IBO (impactbiomedinc.com) - Proyeksi bathi mangsa ngarep|TNFA (TNF Pharmaceuticals) - Bathi resik mangsa ngarep|Bathi sing dikarepake cbdmd.com (YCBD)|Prakiraan bathi perusahaan PainReform Ltd|Proyeksi bathi mangsa ngarep CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Bathi resik sing dikarepake|OPTN - Bathi sing dikarepake|Pieris Pharmaceuticals - Bathi resik mangsa ngarep|PROC (Procaps Group) - Bathi mangsa ngarep|PTPI - Prakiraan bathi perusahaan|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan